Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Rowehl, Rebecca A ^a   Burke, Stephanie ^a   Bialkowska, Agnieszka B ^a   Pettet III, Donald W ^a   Rowehl, Leahana ^a   Li, Ellen ^a   Antoniou, Eric ^b   Zhang, Yuanhao ^c   Bergamaschi, Roberto ^a   Shroyer, Kenneth R ^a   Ojima, Iwao ^c   Botchkina, Galina I ^a,c  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD133 ANTIGEN; CD24 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LGR5 PROTEIN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; PEPTIDES AND PROTEINS; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; TUMOR MARKER;

ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL ADHESION; CELL CLONING; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL INVASION; CELL ISOLATION; CELL MEMBRANE RESISTANCE; CELL PROLIFERATION; CELL SELECTION; CELL STRUCTURE; CLONOGENESIS; COCULTURE; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CARCINOMA; COLORECTAL TUMOR; CYTOLOGY; DRUG SCREENING; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PROCEDURES; SCID MOUSE; SECONDARY; TUMOR CELL LINE;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; MICE, SCID; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84903395133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099091     Document Type: Article

References (78)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29.
2. Hutchinson L, Kirk R (2011) High drug attrition rates - where are we going wrong? Nat Rev Clin Oncol 8:189-90.
3. Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, et al. (2011) Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci USA 108:18708-13.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-11. (Pubitemid 33041634)
5. Clarke MF, Fuller M (2006) Stem cells and cancer: Two faces of eve. Cell 124:1111-5.
6. Mimeault M, Batra SK (2010) New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence. Histol Histopathol 25:1057-73.
7. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. PNAS USA 104:10158-63. (Pubitemid 47175279)
8. O'Brien CA, Pollett A, Gallinger S, Dick J (2007) A human colon cancer cell capable of initiating timor growth in immunodeficient mice. Nature. 445:106-10. (Pubitemid 46067310)
9. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-5. (Pubitemid 46067311)
10. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, et al. (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66:7843-8. (Pubitemid 44299144)
11. Dirks PB (2006) Cancer: Stem cells and brain tumors. Nature 444:687-8.
12. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, et al. (2006). Chemotherapy resistance of glioblastoma stem cells. Cell Death and Differentiation 13:1238-41. (Pubitemid 43905604)
13. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, et al. (2007) WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104:618-23. (Pubitemid 46123074)
14. Todaro M, Alea MP, Stefano AB, Cammareri P, Vermeulen L, et al. (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1:389-402. (Pubitemid 47506537)
15. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, et al. (2009) PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4:226-235.
16. Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, et al. (2009) Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106:162881-116286.
17. Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, et al. (2009) Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX. Transl Oncol 2:321-328.
18. Ohata H, Ishiguro T, Aihara Y, Sato A, Sakai H, et al. (2012) Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells. Cancer Res 72:5101-10.
19. Taylor BS, Barretina J, Socci ND, Decarolis P, Ladanyi M, et al. (2008) Functional copy-number alterations in cancer. PLoS One 3:e3179.
20. Gaiser T, Camps J, Meinhardt S, Wangsa D, Nguyen QT, et al. (2011) Genome and transcriptome profiles of CD133-positive colorectal cancer cells. Am J Pathol 178:1478-88.
21. Patrawala L, Calhoun T, Schneider-Broussardectedou J, Claypool K, Tang DG (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65:6207-6219. (Pubitemid 40994406)
22. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313-323. (Pubitemid 47355323)
23. Miki J, Furusato B, Li H, Gu Y, Takahashi H, et al. (2007) Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67:3153-61. (Pubitemid 46724852)
24. Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, et al. (2009) Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis 26:433-46.
25. Guo C, Liu H, Zhang BH, Cadaneanu RM, Mayle AM, et al. (2012) Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability. PLoS ONE 7(4):e34219.
26. Park JG, Gazdar AF (1996) Biology of colorectal and gastric cancer cell lines. J Cell Biochem Suppl 24:131-41.
27. Dangles-Marie V, Pocard M, Richon S, Weiswald LB, Assayag F, et al. (2007) Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res 67:398-407. (Pubitemid 46142799)
28. Kobayashi S, Yamada-Okabe H, Suzuki M, Natori O, Kato A, et al. (2012) LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. Stem Cells 30:2631-44.
29. Ray S, Langan RC, Mullinax JE, Koizumi T, Xin HW, et al. (2012) Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies. J Cancer 3:196-206.
30. Rao GH, Liu HM, Li BW, Hao JJ, Yang YL, et al. (2013) Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs. Acta Pharmacol Sin 34:793-804.
31. Peehl DM (2004) Are primary cultures realistic models of prostate cancer? J Cell Biochem 91:185-195.
32. Botchkina GI, Zuniga ES, Rowehl RH, Park R, Bhalla R, et al. (2013) Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24. PLoS ONE 8(9):e69884.
33. Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, et al. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12:468-76.
34. Fredebohm J, Boettcher M, Eisen C, Gaida MM, Heller A, et al. (2012) Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system. PLoS One 7(11):e48503.
35. Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, et al. (2012) Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 10:29.
36. Antoniou E, Taft R (2012) Gene expression in mouse oocytes by RNA-Seq. Methods Mol Biol 825:237-51.
37. Streppel MM, Lata S, DelaBastide M, Montgomery EA, Wang J, et al. (2013) Next generation sequencing of endoscopic biopsies identifies ARID1A as a tumor suppressor gene in Barrett's esophagus. Oncogene 2013:1-11
38. Alhamdani MS, Youns M, Buchholz M, Gress TM, Beckers MC, et al. (2012) Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines. J Proteomics 75:3747-59.
39. Failli A, Consolini R, Legitimo A, Spisni R, Castagna M, et al. (2009) The challenge of culturing human colorectal tumor cells: establishment of a cell culture model by the comparison of different methodological approaches. Tumori 95:343-7.
40. Perez-Escuredo J, García Martínez J, García- Inclán C, Vivanco B, Costales M, et al. (2011) Establishment and genetic characterization of an immortal tumor cell line derived from intestinal-type sinonasal adenocarcinoma. Cell Oncol 34:23-31.
41. Friedrich J, Siedel C, Ebner R, Kunz-Schughart LA (2009) Spheroid-based drug screening: considerations and practical approach. Nature Protocols 4:309-24.
42. Kirkland SC (2009) Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br J Cancer 101:320-6.
43. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-15. (Pubitemid 351636299)
44. Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MSJ, Crawford H, et al. (2009) Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Cancer Genomics Proteomics 6:19-30.
45. Matsuda Y, Naito Z, Kawahara K, Nakazawa N, Korc M, et al. (2011) Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis. Cancer Biol Ther 11:512-523.
46. Weihua Z, Lin Q, Ramoth AJ, Fan D, Fidler IJ (2011) Formation of solid tumors by a single multinucleated cancer cell. Cancer 117:4092-9.
47. Yu Q, Stamenkovic I (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35-48. (Pubitemid 29045114)
48. Zoller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nature Rev Cancer 11:254-67.
49. Wu Y, Jin M, Xu H, Shimin Z, He S, et al. (2010) Clinicopathologic significance of HIF-1a, CXCR4, and VEGF expression in colon cancer. Clin Dev Immunol 2010:537531.
50. Zheng X, Xie Q, Li S, Zhang W (2011) CXCR4-positive subset of glioma is enriched for cancer stem cells. Oncol Res 19:555-561.
51. Zhang NH, Li J, Li Y, Zhang XT, Liao WT, et al. (2012) Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients. Exp Ther Med 3:973-82.
52. Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ, et al. (2012) CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med 10:85.
53. Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, et al. (2013) Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. Onco Targets Ther 6:1347-61.
54. Becker L, Huang Q, Mashimo H (2008) Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. ScientificWorldJournal 8:1168-76.
55. Amsterdam A, Raanan C, Schreiber L, Freyhan O, Fabrikant Y, et al. (2013) Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells. Acta Histochem 115:320-9.
56. Attard G, Rizzo S, Ledaki I, Clark J, Reid AH, et al. (2009) A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies. Prostate 69:1507-20.
57. Hermeking H (2012) MicroRNAs in the p53 network: micromanagement of tumour suppression. Nature Rev Cancer 12:613-626.
58. Jiang XH, Lam SK, Lin MCM, Jiang SH, Kung HF, et al. (2002) Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway. Oncogene 21:6113-22.
59. Wong BC, Jiang Xh, Fan XM, Lin MC, Jiang SH, et al. (2003) Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer. Oncogene 22:1189-97.
60. Perinchery G, Sasaki M, Angan A, Kumar V, Carroll P, et al. (2000) Deletion of Y-chromosome specific genes in human prostate cancer. J Urol 163:1339-42 (Pubitemid 30169436)
61. Vijayakumar S, Garcia D, Hensel CH, Banerjee M, Bracht T, et al. (2005) The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice. Genes Chromosomes Cancer 44:365-372. (Pubitemid 41476787)
62. Luo JH, Yu YP (2003) Genetic factors underlying prostate cancer. Expert Rev Mol Med 5:1-26.
63. Nieländer I, Martín-Subero JI, Wagner F, Baudis M, Gesk S, et al. (2008) Recurrent loss of the Y chromosome and homozygous deletions within the pseudo-autosomal region 1: association with male predominance in mantle cell lymphoma. Haematol 93:949-950. (Pubitemid 351821740)
64. Gordon DJ, Resio B, Pellman D (2012) Causes and consequences of aneuploidy in cancer. Nature Rev Genet 13:189-203.
65. Vermeulen L, Todaro M, de Sousa MF, Sprick MR, Kemper K, et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 105:13427-32.
66. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, et al. (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69:3382-9.
67. Takeda K, Kinoshita I, Shimizu Y, Matsuno Y, Shichinohe T, et al. (2011) Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res 31:263-70.
68. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, et al. (2008) CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15:2927-33.
69. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 118:2111-20. (Pubitemid 351872330)
70. Wang C, Xie J, Guo J, Manning HC, Gore JC, et al. (2012) Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Oncol Rep 28:1301-8.
71. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, et al. (2009) Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457:603-7.
72. Puglisi MA, Sgambato A, Saulnier N, Rafanelli F, Barba M, et al. (2009) Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer. Eur Rev Med Pharmacol Sci 2009:55-62.
73. Du L, Wang H, He L, Zhang J, Ni B, et al. (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14:6751-60.
74. Horst D, Kriegl L, Engel J, Kirchner T, Jung A (2009) Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest 27:844-50.
75. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-51. (Pubitemid 41713363)
76. Rowehl RH, Crawford H, Dufour A, Leyfman Y, Ju J, et al. (2008) Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line. Cancer Genomics Proteomics 5:301-9.
77. Zhu Z, Hao X, Yan M, Yao M, Ge C, et al. (2010) Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma. Int J Cancer 126:2067-78.
78. Muraro MG, Mele V, Däster S, Han J, Heberer M, et al. (2012) CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Stem Cells Transl Med 1:592-603.